(Q28287939)

English

APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy (English)

0 references

1 reference

1 reference

Octavian Bucur

1

0 references

Subrata Ray

series ordinal

2

0 references

Maria Cristina Bucur

series ordinal

3

0 references

Alexandru Almasan

series ordinal

4

0 references

language of work or name

English

0 references

publication date

1 May 2006

0 references

2006

0 references

published in

Frontiers in Bioscience

0 references

volume

11

0 references

issue

1

0 references

page(s)

1549-68

0 references

1549

0 references

cites work

Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/api/v1/citations/10.1128/JVI.79.3.1367-1378.2005

retrieved

30 December 2023

Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand.

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/api/v1/citations/10.1099/VIR.0.80531-0

retrieved

30 December 2023

Identifiers

0 references

0 references

ResearchGate publication ID

7401486

0 references

(Q28287939)

APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)